Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03985189
Recruitment Status : Active, not recruiting
First Posted : June 13, 2019
Last Update Posted : December 10, 2019
Sponsor:
Information provided by (Responsible Party):
Kyowa Kirin Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 30, 2021
Estimated Study Completion Date : September 30, 2021